The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...

This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing ...

Researchers estimated 7.5% more U.S. children would get cavities, affecting 25.4 million additional teeth, if fluoridation ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

The combined impacts of an immigration crackdown and slashing Medicaid budgets could create an exodus of long-term care ...

An experimental COPD drug from Sanofi and Regeneron showed mixed results in a pair of studies, sending the companies' shares ...

Little noticed, the ACA reforms in the tax bill could lower enrollment about as much as Medicaid cuts will, and in many of ...

Wafik El-Deiry, a Brown University cancer researcher and pandemic-era free speech advocate, is calling for a budget for the ...